Immunology and Allergy

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


1804 publications

... | 2018 | 2017 | 2016 | 2015 | ...
2018
CD32<sup>+</sup> and PD-1<sup>+</sup> Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
Noto A., Procopio F.A., Banga R., Suffiotti M., Corpataux J.M., Cavassini M., Riva A., Fenwick C., Gottardo R., Perreau M. et al., 2018/10/15. Journal of virology, 92 (20). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EFF772664CD3]
Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.
Lazzarino T., Martenet S., Mamin R., Du Pasquier R.A., Peters S., Perreau M., Muller O., Hugli O., Cavassini M., Darling KEA, 2018/10/03. BMJ open, 8 (10) pp. e021203. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B109EF61AEB]
 
Efficient B cell Depletion With Rituximab Despite Massive Proteinuria.
Halfon M., Pascual M., Aubert V., Rotman S., Yannick M.D., 2018/10. Transplantation, 102 (10) pp. e401-e402. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A39294230312]
 
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M., Rettby N., Perreau M., Pascual M., Pantaleo G., Manuel O., 2018/10/01. Vaccine, 36 (41) pp. 6163-6169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38C298B3CEB2]
Influenza A Virus Induces Autophagosomal Targeting of Ribosomal Proteins
Becker A. C., Gannage M., Giese S., Hu Z., Abou-Eid S., Roubaty C., Paul P., Buhler L., Gretzmeier C., Dumit V. I. et al., 2018/10. Mol Cell Proteomics, 17 (10) pp. 1909-1921.
[URN][DOI][Pmid][serval:BIB_4C5CD59E1E29]
 
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs.
Cheng L., Wang Q., Li G., Banga R., Ma J., Yu H., Yasui F., Zhang Z., Pantaleo G., Perreau M. et al., 2018/10/01. The Journal of clinical investigation, 128 (10) pp. 4387-4396. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A76F3B73E54A]
 
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.
Kouyos R.D., Rusert P., Kadelka C., Huber M., Marzel A., Ebner H., Schanz M., Liechti T., Friedrich N., Braun D.L. et al., 2018/09. Nature, 561 (7723) pp. 406-410. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C1DFE8750F09]
Cholangite biliaire primitive : mise à jour [Primary biliary cholangitis : an update]
Vieira Barbosa J., Vionnet J., Sciarra A., Sempoux C., Aubert V., Moradpour D., Fraga Christinet M., 2018/08/29. Revue medicale suisse, 14 (616) pp. 1489-1494. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B0081B423DB4]
 
Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season.
Kettner A., DellaCorte G., de Blay F., Jacobsen L., Jutel M., Worm M., Charlon V., Simonsen K., Reymond C., Spertini F., 2018/08. The Journal of allergy and clinical immunology, 142 (2) pp. 678-680.e7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0DB48862B6C0]
Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells.
Tran TTP, Eichholz K., Amelio P., Moyer C., Nemerow G.R., Perreau M., Mennechet FJD, Kremer E.J., 2018/08. PLoS pathogens, 14 (8) pp. e1007127. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_444EDA3E6EFA]
 
Les lymphohistiocytoses hémophagocytaires [Hemophagocytic Lymphohistiocytosis]
Stalder G., Ribi C., Duchosal M.A., 2018/08. Praxis, 107 (16) pp. 902-911. Peer-reviewed.
[DOI][Pmid][serval:BIB_D46E28896440]
 
Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.
Marchetti T., Ribi C., Perneger T., Trendelenburg M., Huynh-Do U., de Moerloose P., Chizzolini C., 2018/08/01. Rheumatology, 57 (8) pp. 1350-1357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37D7EB2120E6]
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.
Kadelka C., Liechti T., Ebner H., Schanz M., Rusert P., Friedrich N., Stiegeler E., Braun D.L., Huber M., Scherrer A.U. et al., 2018/06/04. The Journal of experimental medicine, 215 (6) pp. 1589-1608. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F22C97F0906]
 
Endocytosis regulation by autophagy proteins in MHC restricted antigen presentation
Keller C. W., Loi M., Ligeon L. A., Gannage M., Lunemann J. D., Munz C., 2018/06. Curr Opin Immunol, 52 pp. 68-73.
[DOI][Pmid][serval:BIB_B83736729CCC]
 
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).
Redelman-Sidi G., Michielin O., Cervera C., Ribi C., Aguado J.M., Fernández-Ruiz M., Manuel O., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S95-S107. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_679ECFFACD23]
Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4+ T cell responses in Tanzanian adults with latent or active tuberculosis
Boillat-Blanco N., Tumbo A.N., Perreau M., Amelio P., Ramaiya K.L., Mganga M., Schindler C., Gagneux S., Reither K., Probst-Hensch N. et al., 2018/06. Immunity, inflammation and disease, 6 (2) pp. 345-353. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E678D6B1F88E]
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.
Gabay C., Fautrel B., Rech J., Spertini F., Feist E., Kötter I., Hachulla E., Morel J., Schaeverbeke T., Hamidou M.A. et al., 2018/06. Annals of the rheumatic diseases, 77 (6) pp. 840-847. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C1D4A65C579D]
Churg-Strauss syndrome with cardiac involvement: case illustration and contribution of CMR in the diagnosis and clinical follow-up.
d'Ersu E., Ribi C., Monney P., Vincenti G., Schwitter J., Rotman S., Hullin R., Regamey J., 2018/05/01. International journal of cardiology, 258 pp. 321-324. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2BC5A8C83FB6]
The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis.
Marzel A., Kusejko K., Weber R., Bruggmann P., Rauch A., Roth J.A., Bernasconi E., Calmy A., Cavassini M., Hoffmann M. et al., 2018/05. Open forum infectious diseases, 5 (5) pp. ofy078. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_284134C473C7]
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.
Yates N.L., deCamp A.C., Korber B.T., Liao H.X., Irene C., Pinter A., Peacock J., Harris L.J., Sawant S., Hraber P. et al., 2018/04/15. Journal of virology, 92 (8) pp. e01843-17 . Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7D182EB82921]
 
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
Saunders K.O., Santra S., Parks R., Yates N.L., Sutherland L.L., Scearce R.M., Balachandran H., Bradley T., Goodman D., Eaton A. et al., 2018/04/15. Journal of virology, 92 (8) p. 1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6319393AA06F]
 
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.
Tanyi J.L., Bobisse S., Ophir E., Tuyaerts S., Roberti A., Genolet R., Baumgartner P., Stevenson B.J., Iseli C., Dangaj D. et al., 2018/04/11. Science translational medicine, 10 (436) pp. NA. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CBC10D090AEF]
 
Immunothérapie sublinguale pourle traitement de la rhinoconjonctivite et l’asthme allergique : guide pratique [Sublingual immunotherapy for the treatment of allergic rhinoconjonctivitis and asthma : a practical approach]
Ghosn J., Spertini F., Comte D., 2018/04/04. Revue medicale suisse, 14 (601) pp. 735-739. Peer-reviewed.
[Pmid][serval:BIB_344CEBAEFAA6]
 
Maladies et complément [Complement in diseases]
Sadallah S., Schifferli J.A., 2018/04/04. Revue medicale suisse, 14 (601) pp. 752-756. Peer-reviewed.
[Pmid][serval:BIB_25CFA3FCF5AB]
 
Nouvelles thérapeutiques et coûts de la médecine []
Spertini F., Seebach J., 2018/04/04. Revue medicale suisse, 14 (601) pp. 723-724. Peer-reviewed.
[Pmid][serval:BIB_87A4E036D2E0]
 
Rhinite allergique saisonnière [Seasonal allergic rhinitis]
Salvadé I., Moi L., Ribi C., Spertini F., 2018/04/04. Revue medicale suisse, 14 (601) pp. 726-730. Peer-reviewed.
[Pmid][serval:BIB_43CB50E772F4]
 
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.
Fraga M., Doerig C., Moulin H., Bihl F., Brunner F., Müllhaupt B., Ripellino P., Semela D., Stickel F., Terziroli Beretta-Piccoli B. et al., 2018/04. Liver international, 38 (4) pp. 619-626. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_989825B85C8C]
 
Morbus-Sjögren-assoziierte schwere retinale Vaskulitis und/oder nekrotisierende Skleritis: 2 Fälle [Sjögren's Disease Associated with Severe Retinal Vasculitis and/or Necrotizing Scleritis: Two Cases]
Lopez Baumann S., Borgeat Kaeser A., Valerio F., Spertini F., Guex-Crosier Y., 2018/04. Klinische Monatsblatter fur Augenheilkunde, 235 (4) pp. 480-482. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2A01EE56362]
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Muller Y.D., Ghaleb N., Rotman S., Vionnet J., Halfon M., Catana E., Golshayan D., Venetz J.P., Aubert V., Pascual M., 2018/04. Transplant international, 31 (4) pp. 451-455. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C54B7A2AC6FE]
Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.
Bobisse S., Genolet R., Roberti A., Tanyi J.L., Racle J., Stevenson B.J., Iseli C., Michel A., Le Bitoux M.A., Guillaume P. et al., 2018/03/15. Nature communications, 9 (1) p. 1092. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10AE95ADCEE8]
Comparison of CyTOF assays across sites: Results of a six-center pilot study.
Leipold M.D., Obermoser G., Fenwick C., Kleinstuber K., Rashidi N., McNevin J.P., Nau A.N., Wagar L.E., Rozot V., Davis M.M. et al., 2018/02. Journal of immunological methods, 453 pp. 37-43. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_52B838044D38]
Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy.
Martins F., Stalder G., Obeid M., 2018/02. Neoplasia, 20 (2) pp. 193-196. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E40BCA1D786F]
Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.
Kühnert D., Kouyos R., Shirreff G., Pečerska J., Scherrer A.U., Böni J., Yerly S., Klimkait T., Aubert V., Günthard H.F. et al., 2018/02. PLoS pathogens, 14 (2) pp. e1006895. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E944D8BBF5C]
Absence of MHC-II expression by lymph node stromal cells results in autoimmunity.
Dubrot J., Duraes F.V., Harlé G., Schlaeppi A., Brighouse D., Madelon N., Göpfert C., Stokar-Regenscheit N., Acha-Orbea H., Reith W. et al., 2018. Life Science Alliance, 1 (6) pp. e201800164. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8398D98F5515]
Antibodies to <i>Chlamydia trachomatis</i> and reproductive health issues in women with SLE: a case-control study.
Santos A., Greub G., Aeby S., Wunder D., Pantaleo G., Ribi C., 2018. Lupus science & medicine, 5 (1) pp. e000293. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B997988DA92E]
Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
Nehring J., Schirmbeck L.A., Friebus-Kardash J., Dubler D., Huynh-Do U., Chizzolini C., Ribi C., Trendelenburg M., 2018. Frontiers in immunology, 9 p. 2090. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35DBB703320E]
Blood CXCR3 (+) CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals.
Banga R., Procopio F.A., Ruggiero A., Noto A., Ohmiti K., Cavassini M., Corpataux J.M., Paxton W.A., Pollakis G., Perreau M., 2018. Frontiers in immunology, 9 p. 144. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_264758601E35]
 
Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.
Candotti F., 2018/01. Journal of clinical immunology, 38 (1) pp. 13-27. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_00549880C4AB]
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity.
Bertels F., Marzel A., Leventhal G., Mitov V., Fellay J., Günthard H.F., Böni J., Yerly S., Klimkait T., Aubert V. et al., 2018/01/01. Molecular biology and evolution, 35 (1) pp. 27-37. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C087F60FDD69]
Effect of high-intensity versus low-intensity praziquantel treatment on HIV disease progression in HIV and <i>Schistosoma mansoni</i> co-infected patients: a randomised controlled trial.
Abaasa A., Asiki G., Obuku Ekii A., Wanyenze J., Pala P., J van Dam G., L A M Corstjens P., Hughes P., Ding S., Pantaleo G. et al., 2018. Wellcome open research, 3 p. 81. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_147F5B316B25]
Firewalls Prevent Systemic Dissemination of Vectors Derived from Human Adenovirus Type 5 and Suppress Production of Transgene-Encoded Antigen in a Murine Model of Oral Vaccination.
Revaud J., Unterfinger Y., Rol N., Suleman M., Shaw J., Galea S., Gavard F., Lacour S.A., Coulpier M., Versillé N. et al., 2018. Frontiers in cellular and infection microbiology, 8 p. 6. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D5D9FE1D5924]
 
Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.
Friebus-Kardash J., Branco L., Ribi C., Chizzolini C., Huynh-Do U., Dubler D., Roux-Lombard P., Dolff S., Kribben A., Eisenberger U. et al., 2018/01/01. Nephrology, dialysis, transplantation, 33 (1) pp. 54-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF84982F47AE]
IRF5 Is a Key Regulator of Macrophage Response to Lipopolysaccharide in Newborns.
Schneider A., Weier M., Herderschee J., Perreau M., Calandra T., Roger T., Giannoni E., 2018. Frontiers in immunology, 9 p. 1597. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_655C09751DD5]
Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
Corthésy B., Bioley G., 2018. Frontiers in immunology, 9 p. 431. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F0D3B0E6284]
 
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells
Delaunay T., Violland M., Boisgerault N., Dutoit S., Vignard V., Munz C., Gannage M., Dreno B., Vaivode K., Pjanova D. et al., 2018. Oncoimmunology, 7 (3) pp. e1407897.
[DOI][Pmid][serval:BIB_91BBDC9BC54E]
Oral Passive Immunization With Plasma-Derived Polyreactive Secretory-Like IgA/M Partially Protects Mice Against Experimental Salmonellosis.
Corthésy B., Monnerat J., Lötscher M., Vonarburg C., Schaub A., Bioley G., 2018. Frontiers in immunology, 9 p. 2970. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A2CEE9ACDB57]
Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.
Dahdal S., Devetzis V., Chalikias G., Tziakas D., Chizzolini C., Ribi C., Trendelenburg M., Eisenberger U., Hauser T., Pasch A. et al., 2018. PloS one, 13 (1) pp. e0188695. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CDB924CD0726]
2017
 
High titers of ADAbs in rheumatic disease patients undergoing anti-TNF therapy is not associated with lupus-like autoimmunity.
Safran A., Perreau M., So A., Zufferey P., 2017/12. Lupus, 26 (14) pp. 1571-1572. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B92621CB16F7]
 
Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs.
Tapia G., Højen J.F., Ökvist M., Olesen R., Leth S., Nissen S.K., VanBelzen D.J., O'Doherty U., Mørk A., Krogsgaard K. et al., 2017/12. The Journal of infection, 75 (6) pp. 555-571. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8AF88D92E5B7]
 
A systematic review and meta-analysis of HCV clearance.
Gauthiez E., Habfast-Robertson I., Rüeger S., Kutalik Z., Aubert V., Berg T., Cerny A., Gorgievski M., George J., Heim M.H. et al., 2017/10. Liver international, 37 (10) pp. 1431-1445. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CC51EE2DCFF5]
Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.
Huang Y., Pantaleo G., Tapia G., Sanchez B., Zhang L., Trondsen M., Hovden A.O., Pollard R., Rockstroh J., Ökvist M. et al., 2017/10. EBioMedicine, 24 pp. 195-204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB6E21477314]
 
Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.
Marzel A., Shilaih M., Turk T., Campbell N.K., Yang W.L., Böni J., Yerly S., Klimkait T., Aubert V., Furrer H. et al., 2017/10. HIV medicine, 18 (9) pp. 667-676. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8067C283625C]
 
Successful therapy with mycophenolic acid in a membranous glomerulonephritis due to Kimura disease
.
Gaillard J., Rotman S., Girardet C., Spertini F., 2017/10. Clinical nephrology, 88 (10) pp. 221-225. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C4C901DA823]
 
Targeted Immune Interventions for an HIV-1 Cure.
Perreau M., Banga R., Pantaleo G., 2017/10. Trends in molecular medicine, 23 (10) pp. 945-961. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CCFE48672672]
 
Therapeutic intranasal instillation of allergen-loaded microbubbles suppresses experimental allergic asthma in mice.
Corthésy B., Bioley G., 2017/10. Biomaterials, 142 pp. 41-51. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2491D3689DB1]
 
Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy.
Vionnet J., Buss G., Mayer C., Sokolov A.A., Borruat F.X., Spertini F., 2017/10. Joint, bone, spine, 84 (5) pp. 615-619. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_54FC5AA250DD]
 
Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
Vionnet J., Pascual M., Testoni B., Combet C., Godat S., Vijgen S., Aubert V., Rubbia-Brandt L., Zoulim F., Moradpour D., 2017/09/16. Hepatology, 67 (2) pp. 791-793 . Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DD329BAFA656]
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
Turk T., Bachmann N., Kadelka C., Böni J., Yerly S., Aubert V., Klimkait T., Battegay M., Bernasconi E., Calmy A. et al., 2017/09/12. eLife, 6 p. 1. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D12FA23D375F]
 
Gas-filled microbubbles: Novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut.
Corthésy B., Bioley G., 2017/09/03. Gut microbes, 8 (5) pp. 511-519. Peer-reviewed.
[DOI][Pmid][serval:BIB_6AF7A20993ED]
 
Vaccination against Salmonella Infection: the Mucosal Way.
Gayet R., Bioley G., Rochereau N., Paul S., Corthésy B., 2017/09. Microbiology and molecular biology reviews, 81 (3). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A3C3E2DC7A23]
 
SIgA-Shigella Immune Complexes Interact with Dectin-1 and SIGNR3 to Differentially Regulate Mouse Peyer's Patch and Mesenteric Lymph Node Dendritic Cell's Responsiveness.
Mikulic J., Bioley G., Corthésy B., 2017/07/21. Journal of molecular biology, 429 (15) pp. 2387-2400. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1013185D5FAB]
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis.
Aguilo N., Gonzalo-Asensio J., Alvarez-Arguedas S., Marinova D., Gomez A.B., Uranga S., Spallek R., Singh M., Audran R., Spertini F. et al., 2017/07/14. Nature communications, 8 p. 16085. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6B52857B61DD]
A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
Meador L.R., Kessans S.A., Kilbourne J., Kibler K.V., Pantaleo G., Roderiguez M.E., Blattman J.N., Jacobs B.L., Mor T.S., 2017/07. Virology, 507 pp. 242-256. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_38561B71F7B3]
 
Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.
Chaigne B., Finckh A., Alpizar-Rodriguez D., Courvoisier D., Ribi C., Chizzolini C., Swiss Clinical Quality Management Program For Rheumatoid Arthritis, Swiss Systemic Lupus Erythematosus Cohort Study Group, 2017/07. Quality of life research, 26 (7) pp. 1767-1775. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D395D31B0FE3]
Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania.
Amelio P., Portevin D., Reither K., Mhimbira F., Mpina M., Tumbo A., Nickel B., Marti H., Knopp S., Ding S. et al., 2017/07. PLoS neglected tropical diseases, 11 (7) pp. e0005817. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_843AC43D04A8]
 
Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-β.
Mikulic J., Longet S., Favre L., Benyacoub J., Corthesy B., 2017/06. Cellular & molecular immunology, 14 (6) pp. 546-556. Peer-reviewed.
[DOI][Pmid][serval:BIB_9F7542E7151A]
Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup.
Bachmann N., Turk T., Kadelka C., Marzel A., Shilaih M., Böni J., Aubert V., Klimkait T., Leventhal G.E., Günthard H.F. et al., 2017/05/23. Retrovirology, 14 (1) p. 33. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2728928372FD]
 
Gene therapy for the treatment of adenosine deaminase-deficient severe combined immune deficiency
Sokolic Robert, Candotti Fabio, 2017/05/22. Expert Opinion on Orphan Drugs, 5 (6) pp. 477-485. Peer-reviewed.
[DOI][serval:BIB_121BF6844E7B]
 
B-cell abnormalities and impact on antibody response in HIV infection.
Noto A., Pantaleo G., 2017/05. Current opinion in HIV and AIDS, 12 (3) pp. 203-208. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B4C8B32F3BDB]
 
Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.
Shaw K.L., Garabedian E., Mishra S., Barman P., Davila A., Carbonaro D., Shupien S., Silvin C., Geiger S., Nowicki B. et al., 2017/05/01. The Journal of clinical investigation, 127 (5) pp. 1689-1699. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_116142C43273]
 
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
García-Arriaza J., Perdiguero B., Heeney J.L., Seaman M.S., Montefiori D.C., Yates N.L., Tomaras G.D., Ferrari G., Foulds K.E., Roederer M. et al., 2017/05/01. Journal of virology, 91 (9). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4AB7B2C38624]
 
Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
Comte D., Karampetsou M.P., Yoshida N., Kis-Toth K., Kyttaris V.C., Tsokos G.C., 2017/05. Arthritis & rheumatology (Hoboken, N.J.), 69 (5) pp. 1035-1044. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BFA22E11CF23]
 
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
Zurawski G., Shen X., Zurawski S., Tomaras G.D., Montefiori D.C., Roederer M., Ferrari G., Lacabaratz C., Klucar P., Wang Z. et al., 2017/05/01. Journal of virology, 91 (9). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57668F63DF01]
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B., Chizzolini C., Perneger T., Trendelenburg M., Huynh-Do U., Dayer E., Stoll T., von Kempis J., Ribi C., Swiss Systemic Lupus Erythematosus Cohort Study Group, 2017/04/28. BMC immunology, 18 (1) p. 17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BF3D03BABBDB]
 
Allergie au liquide séminal [Allergy to human seminal plasma]
Moi L., Salvadé I., Ribi C., 2017/04/05. Revue medicale suisse, 13 (557) pp. 748-753. Peer-reviewed.
[Pmid][serval:BIB_50BD1E79A5CE]
 
Anaphylaxie alimentaire à l’effort : un diagnostic par étapes [Food-dependent exercise-induced anaphylaxis : a stepwise diagnosis]
Gaillard J., Borgeat-Kaeser A., Buss G., Spertini F., 2017/04/05. Revue medicale suisse, 13 (557) pp. 734-738. Peer-reviewed.
[Pmid][serval:BIB_2CF22180C8E7]
 
Disponibilité de la désensibilisation en allergologie aujourd’hui : étape ou tournant historique ?
Harr T., Spertini F., Seebach J., 2017/04/05. Revue medicale suisse, 13 (557) pp. 731-732. Peer-reviewed.
[Pmid][serval:BIB_A1D3CBD9F584]
 
Hypogammaglobulinémie transitoire de l’enfant [Transient hypogammaglobulinemia of infancy]
Bellutti Enders F., Conti F., Candotti F., Angelini F., 2017/04/05. Revue medicale suisse, 13 (557) pp. 739-742. Peer-reviewed.
[Pmid][serval:BIB_32D9F981D90B]
 
Séquençage à haut débit : outil de diagnostic des déficits immunitaires héréditaires [Next generation sequencing : a diagnostic tool for inherited immune defects]
Droz-Georget S., Riccio O., Royer-Bertrand B., Superti-Furga A., Candotti F., 2017/04/05. Revue medicale suisse, 13 (557) pp. 763-766. Peer-reviewed.
[Pmid][serval:BIB_5CC64A51219F]
 
Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
Comte D., Karampetsou M.P., Kis-Toth K., Yoshida N., Bradley S.J., Kyttaris V.C., Tsokos G.C., 2017/04. Arthritis & rheumatology, 69 (4) pp. 808-813. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C11D2FA9BFDB]
 
Identification of a novel HLA-B*18 allele, B*18:119, using sequence-based typing in a caucasoid individual.
André C., Pantaleo G., Aubert V., 2017/04. HLA, 89 (4) pp. 244-245. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2543D5E2841D]
 
Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
Kletenkov K., Hoffmann D., Böni J., Yerly S., Aubert V., Schöni-Affolter F., Struck D., Verheyen J., Klimkait T., Swiss HIV Cohort Study, 2017/04/01. The Journal of antimicrobial chemotherapy, 72 (3) pp. 866-875. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06F222D1E200]
Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™.
Vescovo P., Rettby N., Ramaniraka N., Liberman J., Hart K., Cachemaille A., Piveteau L.D., Zanoni R., Bart P.A., Pantaleo G., 2017/03/27. Vaccine, 35 (14) pp. 1782-1788. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A7C81D7FFA31]
 
Etat fébrile avec neutrophilie, éruption cutanée et perturbation des tests hépatiques
Fischer Jessica Valeria, Maitre Sylvie, Lamy Olivier, Ribi Camillo, 2017/03/14. Forum Médical Suisse ‒ Swiss Medical Forum, 17 (11).
[DOI][serval:BIB_74C415653F65]
Consensus-based recommendations for the management of juvenile dermatomyositis.
Enders F.B., Bader-Meunier B., Baildam E., Constantin T., Dolezalova P., Feldman B.M., Lahdenne P., Magnusson B., Nistala K., Ozen S. et al., 2017/02. Annals of the rheumatic diseases, 76 (2) pp. 329-340. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C3D9D19C2AA3]
 
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies.
Petrovas C., Ferrando-Martinez S., Gerner M.Y., Casazza J.P., Pegu A., Deleage C., Cooper A., Hataye J., Andrews S., Ambrozak D. et al., 2017/01/18. Science translational medicine, 9 (373) p. 373. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6300DD2A65E6]
 
Allergologie-immunologie Clinique. De l’espoir pour les pathologies inflammatoires chroniques : l’antirécepteur de l’IL-6 tocilizumab [Hope for chronic inflammatory diseases : the anti-IL-6 receptor monoclonal antibody tocilizumab]
Spertini F., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 20-22. Peer-reviewed.
[Pmid][serval:BIB_AC5DE6E8643E]
 
Allergologie-immunologie clinique. Nouveautés dans le traitement de l’asthme sévère [Innovations in the treatment of severe asthma]
Buss G., Spertini F., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 18-19. Peer-reviewed.
[Pmid][serval:BIB_2BCCEEBAD00E]
 
Allergologie-immunologie Clinique. Sensibilité au blé non cœliaque – la fin d’un mythe ? [Non-celiac wheat sensitivity - growing evidence for a wheat-dependent immune-mediated disease]
Ribi C., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 16-17. Peer-reviewed.
[Pmid][serval:BIB_C76CAE91362D]
Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid.
Castiglioni P., Hartley M.A., Rossi M., Prevel F., Desponds C., Utzschneider D.T., Eren R.O., Zangger H., Brunner L., Collin N. et al., 2017. PLoS Neglected Tropical Diseases, 11 (1) pp. e0005240. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_18963158FCAB]
Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.
Karampetsou M.P., Comte D., Kis-Toth K., Kyttaris V.C., Tsokos G.C., 2017. PloS one, 12 (10) pp. e0186073. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E18CDAA4A0A5]
Human Bronchial Epithelial Cells Induce CD141/CD123/DC-SIGN/FLT3 Monocytes That Promote Allogeneic Th17 Differentiation.
Gazdhar A., Blank F., Cesson V., Lovis A., Aubert J.D., Lazor R., Spertini F., Wilson A., Hostettler K., Nicod L.P. et al., 2017. Frontiers in immunology, 8 p. 447. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D80E11236419]
 
Infections Associated with Immunobiologics
Delaloye Julie, Conrad Curdin, Gilliet Michel, Pantaleo Giuseppe, Ribi Camillo, 2017. pp. 796-804.e2 dans Infectious Diseases, Elsevier.
[DOI][serval:BIB_06C1D35B4310]
 
Le syndrome de Widal en pratique clinique []
Borgeat Kaeser A., Ribi C., 2017. Praxis, 106 (22) pp. 1243-1249. Peer-reviewed.
[DOI][Pmid][serval:BIB_1320A169B273]
Oral Immunotherapy With Partially Hydrolyzed Wheat-Based Cereals: A Pilot Study.
Lauener R., Eigenmann P.A., Wassenberg J., Jung A., Denery-Papini S., Sjölander S., Pecquet S., Fritsché R., Zuercher A., Wermeille A. et al., 2017. Clinical medicine insights. Pediatrics, 11 p. 1179556517730018. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5639F5B6A71F]
Plasma-Derived Polyreactive Secretory-Like IgA and IgM Opsonizing Salmonella enterica Typhimurium Reduces Invasion and Gut Tissue Inflammation through Agglutination.
Bioley G., Monnerat J., Lötscher M., Vonarburg C., Zuercher A., Corthésy B., 2017. Frontiers in immunology, 8 p. 1043. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3414A37CD9DF]
 
SLE-Associated Defects Promote Altered T Cell Function.
Crispin J.C., Hedrich C.M., Suárez-Fueyo A., Comte D., Tsokos G.C., 2017. Critical reviews in immunology, 37 (1) pp. 39-58. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B94359FDEE6B]
TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.
Kaufmann SHE, Dockrell H.M., Drager N., Ho M.M., McShane H., Neyrolles O., Ottenhoff THM, Patel B., Roordink D., Spertini F. et al., 2017. Frontiers in immunology, 8 p. 1203. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5787FD5D2175]
 
The autophagy machinery restrains iNKT cell activation through CD1D1 internalization
Keller C. W., Loi M., Ewert S., Quast I., Theiler R., Gannage M., Munz C., De Libero G., Freigang S., Lunemann J. D., 2017. Autophagy, 13 (6) pp. 1025-1036.
[DOI][Pmid][serval:BIB_59DEF07089A8]
2016
 
Blockade of C5 in Severe Acute Postinfectious Glomerulonephritis Associated With Anti-Factor H Autoantibody.
Chehade H., Rotman S., Frémeaux-Bacchi V., Aubert V., Sadallah S., Sifaki L., Salomon R., Pascual M., 2016/12. American journal of kidney diseases : the official journal of the National Kidney Foundation, 68 (6) pp. 944-948. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDAC08A45996]
 
Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
Girard C., Rech J., Brown M., Allali D., Roux-Lombard P., Spertini F., Schiffrin E.J., Schett G., Manger B., Bas S. et al., 2016/12. Rheumatology (Oxford, England), 55 (12) pp. 2237-2247. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_65E498D44C67]
 
Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
Hafner A.M., Corthésy B., Textor M., Merkle H.P., 2016/11/30. International journal of pharmaceutics, 514 (1) pp. 176-188. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C82562E20D9B]
Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo.
Ciarlo E., Heinonen T., Herderschee J., Fenwick C., Mombelli M., Le Roy D., Roger T., 2016/11/29. Scientific reports, 6 p. 37944. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB627C7BE2E8]
pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.
Ozga A.J., Moalli F., Abe J., Swoger J., Sharpe J., Zehn D., Kreutzfeldt M., Merkler D., Ripoll J., Stein J.V., 2016/11/14. The Journal of experimental medicine, 213 (12) pp. 2811-2829. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9948D26FD645]
 
Determinants of HIV-1 broadly neutralizing antibody induction.
Rusert P., Kouyos R.D., Kadelka C., Ebner H., Schanz M., Huber M., Braun D.L., Hozé N., Scherrer A., Magnus C. et al., 2016/11. Nature medicine, 22 (11) pp. 1260-1267. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E6B22356AA9D]
 
The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.
Ikawa Y., Uchiyama T., Jagadeesh G.J., Candotti F., 2016/11. Gene therapy, 23 (11) pp. 815-818. Peer-reviewed.
[DOI][Pmid][serval:BIB_620CBE85F0D3]
 
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change.
Pantaleo G., Levy Y., 2016/11. Current opinion in HIV and AIDS, 11 (6) pp. 576-584. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_369C392ACCBE]
A Minimum Epitope Overlap between Infections Strongly Narrows the Emerging T Cell Repertoire.
Oberle S.G., Hanna-El-Daher L., Chennupati V., Enouz S., Scherer S., Prlic M., Zehn D., 2016/10/11. Cell reports, 17 (3) pp. 627-635. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5BEF45DA9A4E]
 
Detection of Reactive Oxygen Species Using MitoSOX and CellROX in Zebrafish
Rissone Alberto, Candotti Fabio, 2016/10/05. Bio-Protocol, 6 (19) pp. NA. Peer-reviewed.
[DOI][serval:BIB_C1F022A936E1]
Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study.
Ducreux J., Houssiau F.A., Vandepapelière P., Jorgensen C., Lazaro E., Spertini F., Colaone F., Roucairol C., Laborie M., Croughs T. et al., 2016/10. Rheumatology (Oxford, England), 55 (10) pp. 1901-1905. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A36F9251EAEC]
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
Dobrota Rucsandra, Maurer Britta, Graf Nicole, Jordan Suzana, Mihai Carina, Kowal-Bielecka Otylia, Allanore Yannick, Distler Oliver, 2016/10. Annals of the Rheumatic Diseases, 75 (10) pp. 1743-1748.
[URN][DOI][WoS][Pmid][serval:BIB_9EB7FA9C3597]
A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland.
Ragonnet-Cronin M.L., Shilaih M., Günthard H.F., Hodcroft E.B., Böni J., Fearnhill E., Dunn D., Yerly S., Klimkait T., Aubert V. et al., 2016/09/19. Scientific reports, 6 p. 32251. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CD1F0CAF1666]
 
Quand un diagnostic peut cacher un autre
Anastasiou Maria, Lamy Oliver, Ribi Camillo, Zufferey Pascal, Gianinazzi Francesco, Benmachiche Malik, 2016/09/06. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (36).
[DOI][serval:BIB_A27FB94F681A]
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.
Oberle C.S., Joos B., Rusert P., Campbell N.K., Beauparlant D., Kuster H., Weber J., Schenkel C.D., Scherrer A.U., Magnus C. et al., 2016/09/05. Retrovirology, 13 (1) p. 62. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F4E96DF335DA]
 
ATGs help MHC class II, but inhibit MHC class I antigen presentation
Loi M., Gannage M., Munz C., 2016/09. Autophagy, 12 (9) pp. 1681-2.
[DOI][Pmid][serval:BIB_FD08CA031BC4]
 
Correlating HIV tropism with immunological response under combination antiretroviral therapy.
Bader J., Schöni-Affolter F., Böni J., Gorgievski-Hrisoho M., Martinetti G., Battegay M., Klimkait T., Swiss HIV Cohort Study, 2016/09. HIV medicine, 17 (8) pp. 615-622. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_34F6E591ED44]
 
Large-scale inference of conjunctive Bayesian networks.
Montazeri H., Kuipers J., Kouyos R., Böni J., Yerly S., Klimkait T., Aubert V., Günthard H.F., Beerenwinkel N., Swiss HIV Cohort Study, 2016/09/01. Bioinformatics, 32 (17) pp. i727-i735. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_827A78409471]
 
Gastroentérite à éosinophiles [Eosinophilic gastrointestinal disorders]
Burgmann K., Brunel C., Sempoux C., Ribi C., Godat S., Moradpour D., Schoepfer A.M., 2016/08/31. Revue medicale suisse, 13 (528) pp. 1430-1433. Peer-reviewed.
[Pmid][serval:BIB_6D936DDE9696]
High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival.
Utzschneider D.T., Alfei F., Roelli P., Barras D., Chennupati V., Darbre S., Delorenzi M., Pinschewer D.D., Zehn D., 2016/08/22. The Journal of experimental medicine, 213 (9) pp. 1819-1834. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B2EBEA9B2D32]
 
Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus.
Comte D., Karampetsou M.P., Kis-Toth K., Yoshida N., Bradley S.J., Mizui M., Kono M., Solomon J.R., Kyttaris V.C., Tsokos G.C., 2016/08/16. Proceedings of the National Academy of Sciences of the United States of America, 113 (33) pp. 9321-9326. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A05555798EB8]
 
Hepatitis E virus infection as a direct cause of neuralgic amyotrophy.
Silva M., Wicki B., Tsouni P., Cunningham S., Doerig C., Zanetti G., Aubert V., Sahli R., Moradpour D., Kuntzer T., 2016/08. Muscle & nerve, 54 (2) pp. 325-327. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BF873E47ECA]
 
Intranasal Vaccination With Salmonella-Derived Serodominant Secreted Effector Protein B Associated With Gas-Filled Microbubbles Partially Protects Against Gut Infection in Mice.
Pigny F., Lassus A., Terrettaz J., Tranquart F., Corthésy B., Bioley G., 2016/08/01. The Journal of infectious diseases, 214 (3) pp. 438-446. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_92738AAE6623]
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
Bousquet J., Schünemann H.J., Hellings P.W., Arnavielhe S., Bachert C., Bedbrook A., Bergmann K.C., Bosnic-Anticevich S., Brozek J., Calderon M. et al., 2016/08. The Journal of allergy and clinical immunology, 138 (2) pp. 367-374.e2. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_485487DB6928]
 
Notch Signaling Regulates the Homeostasis of Tissue-Restricted Innate-like T Cells.
Chennupati V., Koch U., Coutaz M., Scarpellino L., Tacchini-Cottier F., Luther S.A., Radtke F., Zehn D., MacDonald H.R., 2016/08/01. Journal of immunology, 197 (3) pp. 771-782. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6B2134FFAED]
 
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.
Scherrer A.U., Yang W.L., Kouyos R.D., Böni J., Yerly S., Klimkait T., Aubert V., Cavassini M., Battegay M., Hauser C. et al., 2016/08/01. The Journal of infectious diseases, 214 (3) pp. 399-402. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F3F1DBACE436]
Biases affecting injected doses of an experimental drug during clinical trials.
Perrottet N., Brunner-Ferber F., Grouzmann E., Spertini F., Biollaz J., Buclin T., Widmer N., 2016/07/16. Trials, 17 (1) p. 321. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4D76936AAE9]
 
Current approaches to assess HIV-1 persistence.
Banga R., Procopio F.A., Perreau M., 2016/07. Current opinion in HIV and AIDS, 11 (4) pp. 424-431. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5025934AA54D]
Effect of Schistosoma mansoni Infection on Innate and HIV-1-Specific T-Cell Immune Responses in HIV-1-Infected Ugandan Fisher Folk.
Obuku A.E., Asiki G., Abaasa A., Ssonko I., Harari A., van Dam G.J., Corstjens P.L., Joloba M., Ding S., Mpendo J. et al., 2016/07. AIDS research and human retroviruses, 32 (7) pp. 668-675. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FB39146F35F0]
 
PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals.
Banga R., Procopio F.A., Noto A., Pollakis G., Cavassini M., Ohmiti K., Corpataux J.M., de Leval L., Pantaleo G., Perreau M., 2016/07. Nature medicine, 22 (7) pp. 754-761. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FCD5348987A9]
 
PML risk stratification using anti-JCV antibody index and L-selectin.
Schwab N., Schneider-Hohendorf T., Pignolet B., Spadaro M., Görlich D., Meinl I., Windhagen S., Tackenberg B., Breuer J., Cantó E. et al., 2016/07. Multiple sclerosis, 22 (8) pp. 1048-1060. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47C09F0E3895]
 
Strategies for targeting residual HIV infection.
Chomont N., Perreau M., 2016/07. Current opinion in HIV and AIDS, 11 (4) pp. 359-361. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28EAD4357E9E]
 
Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.
Perraudin C., Bourdin A., Spertini F., Berger J., Bugnon O., 2016/07. Journal of clinical immunology, 36 (5) pp. 502-510. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6B4EC2D560E6]
 
Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production.
Karampetsou M.P., Comte D., Kis-Toth K., Terhorst C., Kyttaris V.C., Tsokos G.C., 2016/06/15. Journal of immunology, 196 (12) pp. 4915-4924. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_85ABECC56B2B]
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.
Shilaih M., Marzel A., Yang W.L., Scherrer A.U., Schüpbach J., Böni J., Yerly S., Hirsch H.H., Aubert V., Cavassini M. et al., 2016/06/14. Scientific reports, 6 p. 27580. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0C3A602D0EF8]
73-05: Focal Hypermetabolic Left Ventricular Cardiomyopathy: An Underdiagnosed Life-threatening Arrhythmogenic Disease
Porretta Alessandra Pia, Park Chan-Il, Di Bernardo Stefano, Bisch Laurence, Schläpfer Jürg, Pascale Patrizio, Buss Guillaume, Prior John, Pruvot Etienne, 2016/06. pp. i57-i57 dans EP Europace.
[URN][DOI][serval:BIB_E81171AB3D3B]
 
Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Salvadé I., Aubert V., Venetz J.P., Golshayan D., Saouli A.C., Matter M., Rotman S., Pantaleo G., Pascual M., 2016/06. Human immunology, 77 (6) pp. 483-489. Peer-reviewed.
[DOI][Pmid][serval:BIB_04243BC5CAD3]
 
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.
Scherrer A.U., von Wyl V., Yang W.L., Kouyos R.D., Böni J., Yerly S., Klimkait T., Aubert V., Cavassini M., Battegay M. et al., 2016/05/15. Clinical infectious diseases, 62 (10) pp. 1310-1317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3E6EC9A4633]
Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.
Gardiol C., Voumard R., Cochet C., de Vallière S., 2016/05. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 35 (5) pp. 839-845. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_65E6CEEE014F]
 
Target Density, Not Affinity or Avidity of Antigen Recognition, Determines Adoptive T Cell Therapy Outcomes in a Mouse Lymphoma Model.
Segal G., Prato S., Zehn D., Mintern J.D., Villadangos J.A., 2016/05/01. Journal of immunology, 196 (9) pp. 3935-3942. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F4F7E1C3D10]
 
"Qui s'y frotte s'y pique": réactions urticariennes aux insectes de nos regions [If you go looking for trouble you'll find it. Urticarial reactions to insects of our local areas]
Maitre S., Kaeser A., Di Lucca J., Spertini F., Ribi C., 2016/04/06. Revue medicale suisse, 12 (513) pp. 691-697. Peer-reviewed.
[Pmid][serval:BIB_6937F63A1071]
 
Syndrome de Sjögren: quand le suspecter et comment le confirmer? [Sjögren's syndrome: when to suspect and how to confirm?]
Liapi A., Horisberger A., François S., Ribi C., 2016/04/06. Revue medicale suisse, 12 (513) pp. 698-702. Peer-reviewed.
[Pmid][serval:BIB_2DE66B2BCA26]
 
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
Asbach B., Kliche A., Köstler J., Perdiguero B., Esteban M., Jacobs B.L., Montefiori D.C., LaBranche C.C., Yates N.L., Tomaras G.D. et al., 2016/04. Journal of virology, 90 (8) pp. 4133-4149. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C0177FF88AB3]
Type I interferonopathies in pediatric rheumatology.
Volpi S., Picco P., Caorsi R., Candotti F., Gattorno M., 2016/03/04. Pediatric rheumatology online journal, 14 (1) p. 35. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F53B15A22E70]
 
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational study
Lazarou Ilias, Finckh Axel, Fischer Lara, Ribi Camillo, Gascon Danielle, Seebach Jörg D., Guerne Pierre-André, 2016/03. Joint Bone Spine, 83 (2) pp. 191-197.
[DOI][WoS][Pmid][serval:BIB_3C9D59DD6904]
 
Allergologie. Traitement de l'angiœdème à bradykinine non héréditaire d'origine médicamenteuse [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin]
Muller Y., Harr T., 2016/01/13. Revue medicale suisse, 12 (500) pp. 11-12. Peer-reviewed.
[Pmid][serval:BIB_321707BFD259]
 
A case for preART-adjusted endpoints in HIV therapeutic vaccine trials.
Huang Y., Zhang L., Jolliffe D., Hovden A.O., Ökvist M., Pantaleo G., Sommerfelt M.A., 2016. Vaccine, 34 (10) pp. 1282-1288. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_59B96F151F7F]
Advances of gene therapy for primary immunodeficiencies.
Candotti F., 2016. F1000research, 5 p. 31. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7FF778D09709]
 
Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
Rochereau N., Pavot V., Verrier B., Jospin F., Ensinas A., Genin C., Corthésy B., Paul S., 2016. Journal of Allergy and Clinical Immunology, 137 (1) pp. 214-222.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_872D2286E800]
 
Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
Spertini F., DellaCorte G., Kettner A., de Blay F., Jacobsen L., Jutel M., Worm M., Charlon V., Reymond C., 2016. Journal of Allergy and Clinical Immunology, 138 (1) pp. 162-168. Peer-reviewed.
[DOI][Pmid][serval:BIB_1F04330FEEDB]
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky D.J., Abdelmohsen K., Abe A., Abedin M.J., Abeliovich H., Acevedo Arozena A., Adachi H., Adams C.M., Adams P.D., Adeli K. et al., 2016/01. Autophagy, 12 (1) pp. 1-222.
[URN][DOI][WoS][Pmid][serval:BIB_D1B3A2339998]
 
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study.
Marzel A., Shilaih M., Yang W.L., Böni J., Yerly S., Klimkait T., Aubert V., Braun D.L., Calmy A., Furrer H. et al., 2016. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 62 (1) pp. 115-122. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BB1D1B3BB7A2]
ICER is requisite for Th17 differentiation.
Yoshida N., Comte D., Mizui M., Otomo K., Rosetti F., Mayadas T.N., Crispín J.C., Bradley S.J., Koga T., Kono M. et al., 2016. Nature Communications, 7 p. 12993. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A6AFD41C6AE7]
 
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.
Fellmann F., Angelini F., Wassenberg J., Perreau M., Arenas Ramirez N., Simon G., Boyman O., Demaria O., Christen-Zaech S., Hohl D. et al., 2016. Journal of Allergy and Clinical Immunology, 137 (4) pp. 1189-96.e1-2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D933D1DD0E0F]
Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells.
Eichholz K., Bru T., Tran T.T., Fernandes P., Welles H., Mennechet F.J., Manel N., Alves P., Perreau M., Kremer E.J., 2016. Plos Pathogens, 12 (9) pp. e1005871. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_806D9F146BA4]
 
Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
Balam S., Jafarshad A., Servis C., Frank G., Reed S., Pink R., Druilhe P., Spertini F., Corradin G., 2016. Vaccine, 34 (13) pp. 1566-1574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_072D0AC9EFBC]
 
Kinetics of in Vitro Response to β-Lactoglobulin in Children Allergic to and Tolerant of Cow's Milk Protein.
Chini L., Pacciani V., Corrente S., Monteferrario E., Romiti M.L., Moschese V., Angelini F., 2016. Journal of Investigational Allergology and Clinical Immunology, 26 (4) pp. 275-277. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BB91EB3795BD]
 
Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses
Loi M., Muller A., Steinbach K., Niven J., Barreira da Silva R., Paul P., Ligeon L. A., Caruso A., Albrecht R. A., Becker A. C. et al., 2016. Cell Rep, 15 (5) pp. 1076-1087.
[DOI][Pmid][serval:BIB_1C7C6B3A8741]
Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.
Zhang L., Tschumi B.O., Lopez-Mejia I.C., Oberle S.G., Meyer M., Samson G., Rüegg M.A., Hall M.N., Fajas L., Zehn D. et al., 2016. Cell Reports, 14 (5) pp. 1206-1217. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB0706D22A19]
 
N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.
Volpi S., Santori E., Abernethy K., Mizui M., Dahlberg C.I., Recher M., Capuder K., Csizmadia E., Ryan D., Mathew D. et al., 2016. Blood, 127 (2) pp. 216-220. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3AB2A62512A7]
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions.
Ludigs K., Jandus C., Utzschneider D.T., Staehli F., Bessoles S., Dang A.T., Rota G., Castro W., Zehn D., Vivier E. et al., 2016. Nature Communications, 7 p. 10554. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8FDEF0BFED69]
 
Role of proapoptotic BH3-only proteins in Listeria monocytogenes infection.
Margaroli C., Oberle S., Lavanchy C., Scherer S., Rosa M., Strasser A., Pellegrini M., Zehn D., Acha-Orbea H., Ehirchiou D., 2016. European Journal of Immunology, 46 (6) pp. 1427-1437. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE45D77E6215]
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.
De Santis O., Audran R., Pothin E., Warpelin-Decrausaz L., Vallotton L., Wuerzner G., Cochet C., Estoppey D., Steiner-Monard V., Lonchampt S. et al., 2016. Lancet. Infectious Diseases, 16 (3) pp. 311-320. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1B0E90763307]
 
Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.
Kis-Toth K., Comte D., Karampetsou M.P., Kyttaris V.C., Kannan L., Terhorst C., Tsokos G.C., 2016/01. Arthritis & rheumatology, 68 (1) pp. 164-173. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_43CD194AFC7E]
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
Zurawski G., Zurawski S., Flamar A.L., Richert L., Wagner R., Tomaras G.D., Montefiori D.C., Roederer M., Ferrari G., Lacabaratz C. et al., 2016. Plos One, 11 (4) pp. e0153484. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_980FC2E7134A]
 
The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer
Fonteneau J. F., Brilot F., Munz C., Gannage M., 2016. J Immunol, 196 (1) pp. 64-71.
[DOI][Pmid][serval:BIB_4DBC0252470B]
 
Unite forces to validate biomarkers in the quest for lasting HIV remission.
Rokx C., Vella S., Pantaleo G., Lévy Y., Boucher C.A., 2016. Aids, 30 (11) pp. 1859-1860. Peer-reviewed.
[DOI][Pmid][serval:BIB_69406F112241]
2015
COMPASS identifies T-cell subsets correlated with clinical outcomes.
Lin L., Finak G., Ushey K., Seshadri C., Hawn T.R., Frahm N., Scriba T.J., Mahomed H., Hanekom W., Bart P.A. et al., 2015/06. Nature biotechnology, 33 (6) pp. 610-616. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8FADB11D7063]
 
Allergies et effets indésirabtes dus aux fluoroquinolones [Allergies and adverse events associated with fluoroquinolones]
Muller Y., Andrey D., Emonet S., Harr T., Spoerl D., 2015/04/08. Revue medicale suisse, 11 (469) pp. 826-830. Peer-reviewed.
[Pmid][serval:BIB_062F1B7F272A]
 
Artérite de Horton: recommandations Lausannoises de prise en charge [Giant cell arteritis: guidelines of the University Hospital of Lausanne].
Tsetsou S., Michel P., Ribi C., Hirt L., Kawasaki A., Hugli O., De Leval L., Bart P.A., Waeber G., Meuli R. et al., 2015/02. Revue Médicale Suisse, 11 (461) pp. 411-417.
[Pmid][serval:BIB_14E431815FB6]
 
Allergologie--immunologie clinique. (3.) Nouveaux auto-anticorps dans les myopathies infammatoires et la sclérose systémique [Novel autoantibodies in inflammatory myopathies and systemic sclerosis]
Ribi C., 2015/01/14. Revue medicale suisse, 11 (456-457) pp. 25-29. Peer-reviewed.
[Pmid][serval:BIB_8EC7EA568AA5]
Age-Dependent Defects of Regulatory B Cells in Wiskott-Aldrich Syndrome Gene Knockout Mice.
Yokoyama T., Yoshizaki A., Simon K.L., Kirby M.R., Anderson S.M., Candotti F., 2015. Plos One, 10 (10) pp. e0139729. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E2770578213B]
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
Yang W.L., Kouyos R., Scherrer A.U., Böni J., Shah C., Yerly S., Klimkait T., Aubert V., Furrer H., Battegay M. et al., 2015. Journal of Infectious Diseases, 212 (1) pp. 28-38. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3A0DA18EBA52]
Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome.
Sokolic R., Oden N., Candotti F., 2015. Frontiers in Pediatrics, 3 p. 49. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E2680ABFEEAF]
 
Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of patients with juvenile dermatomyositis correlating with disease activity.
Enders F.B., Delemarre E.M., Kuemmerle-Deschner J., van der Torre P., Wulffraat N.M., Prakken B.P., van Royen-Kerkhof A., van Wijk F., 2015. Annals of the Rheumatic Diseases, 74 (1) pp. 315-317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6323A7AA153F]
Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell Responses.
Kinloch-de Loes S., Dorrell L., Yang H., Hardy G.A., Yerly S., Cellerai C., Vandekerckhove L., De Spielgelaere W., Malatinkova E., Wee Lee Koh W. et al., 2015. Open Forum Infectious Diseases, 2 (4) pp. ofv144. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B9F092E637B9]
 
Capacity for science in sub-Saharan Africa.
Elliott A., Nerima B., Bagaya B., Kambugu A., Joloba M., Cose S., Pantaleo G., Yazdanbakhsh M., Mabey D., Dunne D. et al., 2015. Lancet, 385 (9986) pp. 2435-2437.
[DOI][WoS][Pmid][serval:BIB_FED7CD1753BD]
Combined Use of Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis.
Rozot V., Patrizia A., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., Lazor-Blanchet C., Ohmiti K., Goletti D. et al., 2015. Clinical Infectious Diseases, 60 (3) pp. 432-437. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35203E0F848B]
 
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
Hulot S.L., Korber B., Giorgi E.E., Vandergrift N., Saunders K.O., Balachandran H., Mach L.V., Lifton M.A., Pantaleo G., Tartaglia J. et al., 2015. Journal of Virology, 89 (12) pp. 6462-6480. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9ABE1A5A8729]
 
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.
Terczyńska-Dyla E., Bibert S., Duong F.H., Krol I., Jørgensen S., Collinet E., Kutalik Z., Aubert V., Cerny A., Kaiser L. et al., 2015..
[DOI][WoS][Pmid][serval:BIB_D0FA1809BD1B]
Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms.
Schüpbach J., Niederhauser C., Yerly S., Regenass S., Gorgievski M., Aubert V., Ciardo D., Klimkait T., Dollenmaier G., Andreutti C. et al., 2015. Plos One, 10 (7) pp. e0131828. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_43C24B25E1E7]
 
EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.
Boyman O., Kaegi C., Akdis M., Bavbek S., Bossios A., Chatzipetrou A., Eiwegger T., Firinu D., Harr T., Knol E. et al., 2015. Allergy, 70 (7) pp. 727-754. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA995CE995AA]
 
Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient.
Chehade H., Rotman S., Matter M., Girardin E., Aubert V., Pascual M., 2015. Pediatrics, 135 (2) pp. e551-e555. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2A471BDF7098]
 
Emerging single-cell technologies in immunology.
Herderschee J., Fenwick C., Pantaleo G., Roger T., Calandra T., 2015. Journal of Leukocyte Biology, 98 (1) pp. 23-32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B577FB613E4C]
 
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
García-Arriaza J., Perdiguero B., Heeney J., Seaman M., Montefiori D.C., Labranche C., Yates N.L., Shen X., Tomaras G.D., Ferrari G. et al., 2015. Journal of Virology, 89 (16) pp. 8525-8539. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BC8EC27AA24B]
High level of anti-drug antibodies after intra-articular injection of anti-TNF.
Zufferey P., Perreau M., So A., 2015. Rheumatology, 54 (12) pp. 2291-2292.
[URN][DOI][WoS][Pmid][serval:BIB_7F7C39F91B3A]
Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data.
Lin L., Frelinger J., Jiang W., Finak G., Seshadri C., Bart P.A., Pantaleo G., McElrath J., DeRosa S., Gottardo R., 2015. Cytometry. Part A, 87 (7) pp. 675-682. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A190F236B1C2]
 
Immune correlates of vaccine protection against HIV-1 acquisition.
Corey L., Gilbert P.B., Tomaras G.D., Haynes B.F., Pantaleo G., Fauci A.S., 2015. Science Translational Medicine, 7 (310) pp. 310rv7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8CEE6DB353F7]
 
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model.
Zehn D., Wherry E.J., 2015. pp. 137-152 dans Advances in Experimental Medicine and Biology, Springer.
[DOI][WoS][Pmid][serval:BIB_8448C0E69BC8]
 
Immunoglobulines sous-cutanées et programme d’accompagnement: quel est l‘intérêt des patients ? [Subcutaneous immunoglobulin and support program: what level of interest of patients?]
Bourdin Aline, Berger Jérôme, Früh Aline, Spertini François, Bugnon Olivier, 2015. Revue Médicale Suisse , 11 (469) pp. 831-835. Peer-reviewed.
[Pmid][serval:BIB_81D472BF2900]
Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiency.
Komarow H.D., Sokolic R., Hershfield M.S., Kohn D.B., Young M., Metcalfe D.D., Candotti F., 2015. Orphanet Journal of Rare Diseases, 10 (1) p. 159. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9D71F79E18A7]
In vitro functional correction of Hermansky-Pudlak Syndrome type-1 by lentiviral-mediated gene transfer.
Ikawa Y., Hess R., Dorward H., Cullinane A.R., Huizing M., Gochuico B.R., Gahl W.A., Candotti F., 2015. Molecular Genetics and Metabolism, 114 (1) pp. 62-65. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4EAD5A280AFA]
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013
Wandeler G., Schlauri M., Jaquier M.E., Rohrbach J., Metzner K.J., Fehr J., Ambrosioni J., Cavassini M., Stöckle M., Schmid P. et al., 2015. Open Forum Infectious Diseases, 2 (1) pp. ofv026.
[URN][DOI][Pmid][serval:BIB_C500BBBFB672]
Increases in condomless sex in the Swiss HIV Cohort Study.
Kouyos R.D., Hasse B., Calmy A., Cavassini M., Furrer H., Stöckle M., Vernazza P.L., Bernasconi E., Weber R., Günthard H.F. et al., 2015. Open Forum Infectious Diseases, 2 (2) pp. ofv077. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8E081098C9A0]
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
Delaloye J., Filali-Mouhim A., Cameron M.J., Haddad E.K., Harari A., Goulet J.P., Gomez C.E., Perdiguero B., Esteban M., Pantaleo G. et al., 2015. Journal of Virology, 89 (7) pp. 3819-3832. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3F54B19290C2]
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Perriard G., Mathias A., Enz L., Canales M., Schluep M., Gentner M., Schaeren-Wiemers N., Du Pasquier R.A., 2015. Journal of Neuroinflammation, 12 p. 119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E0A38EB4D79]
 
Long-term persistence of immunity induced by OVA-coupled gas-filled microbubble vaccination partially protects mice against infection by OVA-expressing Listeria.
Bioley G., Lassus A., Terrettaz J., Tranquart F., Corthésy B., 2015. Biomaterials, 57 pp. 153-160.
[DOI][WoS][Pmid][serval:BIB_899CF93A9FBD]
Macroautophagy in Endogenous Processing of Self- and Pathogen-Derived Antigens for MHC Class II Presentation
Duraes F. V., Niven J., Dubrot J., Hugues S., Gannage M., 2015. Front Immunol, 6 p. 459.
[URN][DOI][Pmid][serval:BIB_32E6B1B5B9C1]
 
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Lalive P.H., Bridel C., Ferfoglia R.I., Kaiser L., Du Pasquier R., Barkhof F., Haller S., 2015. Journal of Neurology, Neurosurgery, and Psychiatry, 86 (3) pp. 354-355. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13E5EDA8BCD2]
 
NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retina.
Segarra N.G., Ballhausen D., Crawford H., Perreau M., Campos-Xavier B., van Spaendonck-Zwarts K., Vermeer C., Russo M., Zambelli P.Y., Stevenson B. et al., 2015. American Journal of Medical Genetics. Part A, 167A (12) pp. 2902-2912. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D06FCFC24F20]
 
NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses.
Di Pilato M., Mejías-Pérez E., Zonca M., Perdiguero B., Gómez C.E., Trakala M., Nieto J., Nájera J.L., S Sorzano C.O., Combadière C. et al., 2015. Proceedings of the National Academy of Sciences of the United States of America, 112 (11) pp. E1333-E1342. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C6CDF3DAF499]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University